Literature DB >> 17714522

Development of 16S rRNA-based probes for the identification of Gram-positive anaerobic cocci isolated from human clinical specimens.

A C M Wildeboer-Veloo1, H J M Harmsen, G W Welling, J E Degener.   

Abstract

Fluorescent probes targeted at 16S rRNA were designed for Peptostreptococcus anaerobius and Peptostreptococcus stomatis (Pana134), Parvimonas micra (Pamic1435), Finegoldia magna (Fmag1250), Peptoniphilus asaccharolyticus (Pnasa1254), Peptoniphilus ivorii (Pnivo731), Peptoniphilus harei (Pnhar1466), Anaerococcus vaginalis (Avag1280) and Anaerococcus lactolyticus (Alac1438), based on the 16S rRNA sequences of reference strains and 88 randomly chosen clinical isolates. These strains were also used for validation of the probes. Application of the probes to an additional group of 100 clinical isolates revealed that 87% of Gram-positive anaerobic cocci (GPAC) could be identified with this set of probes. The 16S rRNAs of 13 clinical isolates that could not be identified were sequenced. Most of these isolates were GPAC that were not targeted by the probes. No clinical isolates of Pn. asaccharolyticus were encountered. Near full-length sequences were obtained from 71 of 101 (n = 88 + 13) sequenced clinical isolates. Of these, 25 showed <98% similarity with the homologues of the closest established species. The Fmag1250, Pamic1435, Pnhar1466, Pana134, Pnasa1254 and Pnivo731 probes allowed reliable identification and hybridised with all corresponding isolates. The Avag1280 and Alac1438 probes failed to hybridise with two isolates and one isolate, respectively, because of intra-species variation. However, overall, the set of probes yielded fast and reliable identification for the majority of clinical isolates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17714522     DOI: 10.1111/j.1469-0691.2007.01803.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  8 in total

1.  Molecular detection of transcriptionally active bacteria from failed prosthetic hip joints removed during revision arthroplasty.

Authors:  M P Riggio; Kate E Dempsey; Allan Lennon; David Allan; Gordon Ramage; Jeremy Bagg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-08       Impact factor: 3.267

2.  Antimicrobial susceptibility of clinically relevant Gram-positive anaerobic cocci collected over a three-year period in the Netherlands.

Authors:  A C M Veloo; G W Welling; J E Degener
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

3.  Mistaken identity of Peptoniphilus asaccharolyticus.

Authors:  A C M Veloo; G W Welling; J E Degener
Journal:  J Clin Microbiol       Date:  2011-01-19       Impact factor: 5.948

4.  Septic arthritis of knee joint due to Parvimonas micra.

Authors:  Moni Roy; Ashish Kumar Roy; Sharjeel Ahmad
Journal:  BMJ Case Rep       Date:  2017-11-14

5.  Oral biofilm architecture on natural teeth.

Authors:  Vincent Zijnge; M Barbara M van Leeuwen; John E Degener; Frank Abbas; Thomas Thurnheer; Rudolf Gmür; Hermie J M Harmsen
Journal:  PLoS One       Date:  2010-02-24       Impact factor: 3.240

6.  Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons.

Authors:  Huma Siddiqui; Alexander J Nederbragt; Karin Lagesen; Stig L Jeansson; Kjetill S Jakobsen
Journal:  BMC Microbiol       Date:  2011-11-02       Impact factor: 3.605

7.  Polymicrobial synergy stimulates Porphyromonas gingivalis survival and gingipain expression in a multi-species subgingival community.

Authors:  Julia R Davies; Trupti Kad; Jessica Neilands; Bertil Kinnby; Zdenka Prgomet; Torbjörn Bengtsson; Hazem Khalaf; Gunnel Svensäter
Journal:  BMC Oral Health       Date:  2021-12-15       Impact factor: 2.757

8.  Evaluation of Antibiotic Susceptibility of Gram-Positive Anaerobic Cocci Isolated from Cancer Patients of the N. N. Blokhin Russian Cancer Research Center.

Authors:  Irina I Shilnikova; Natalia V Dmitrieva
Journal:  J Pathog       Date:  2015-12-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.